PRESS RELEASE published on 09/20/2024 at 19:47, 1 year 2 months ago EQS-Adhoc: BRAIN Biotech AG concludes royalty monetization deal for up to EUR 128.88 million on investigational pharma compound deucrictibant with Royalty Pharma BRAIN Biotech AG concludes royalty monetization deal for up to EUR 128.88 million on investigational pharma compound deucrictibant with Royalty Pharma BRAIN Biotech AG Deucrictibant Royalty Pharma Royalty Monetization Deal EUR 128.88 Million
BRIEF published on 08/29/2024 at 07:35, 1 year 3 months ago BRAIN Biotech AG annonce une solide position de trésorerie et prévoit une croissance Résultats Financiers BioProduits BRAIN Biotech SA Prévisions De Croissance Situation De Trésorerie
BRIEF published on 08/29/2024 at 07:35, 1 year 3 months ago BRAIN Biotech AG Reports Robust Cash Position and Forecasts Growth Financial Results Cash Position Growth Forecast BRAIN Biotech AG BioProducts
PRESS RELEASE published on 08/29/2024 at 07:30, 1 year 3 months ago BRAIN Biotech AG presents strong cash position with its 9M reporting and is forecasting good sequential growth in the final quarter of the business year BRAIN Biotech AG reports strong cash position for 9M period, forecasting growth in Q4 FY 23/24. BioProducts segment turnover slightly up, BioScience segment facing decline Cash Position BRAIN Biotech AG BioScience BioProducts Forecasting
BRIEF published on 05/29/2024 at 09:05, 1 year 6 months ago BRAIN Biotech AG annonce Erik de Vries au poste de directeur principal du développement commercial BRAIN Biotech SA Développement Des Affaires Erik De Vries Enzymes Enzymical AG
BRIEF published on 05/29/2024 at 09:05, 1 year 6 months ago BRAIN Biotech AG Announces Erik de Vries as Senior Business Development Director Business Development BRAIN Biotech AG Erik De Vries Enzymicals AG Enzymes
PRESS RELEASE published on 05/29/2024 at 09:00, 1 year 6 months ago BRAIN Biotech AG announces the appointment of Erik de Vries as Senior Business Development Director Enzymes BRAIN Biotech AG appoints Erik de Vries as Senior Business Development Director Enzymes. De Vries will transition from CEO of Enzymicals AG to BRAIN Biotech's Supervisory Board in 2025 Supervisory Board BRAIN Biotech AG Erik De Vries Enzymes Senior Business Development Director
BRIEF published on 05/28/2024 at 07:35, 1 year 6 months ago BRAIN Biotech AG reçoit un paiement d'étape majeur et maintient ses objectifs de fin d'année Résultats Financiers Hausse Des Revenus BRAIN Biotech SA Paiement D'étape Secteur BioProduits
BRIEF published on 05/28/2024 at 07:35, 1 year 6 months ago BRAIN Biotech AG Receives Major Milestone Payment and Maintains Year-End Targets Financial Results Revenue Growth BRAIN Biotech AG Milestone Payment BioProducts Segment
PRESS RELEASE published on 05/28/2024 at 07:30, 1 year 6 months ago BRAIN Biotech AG receives major milestone payment and stays on-track to achieve year end targets BRAIN Biotech AG receives significant milestone payment of € 1.5 million and maintains progress towards year-end goals with strengthened cash position. Half-year results show revenue growth and improved EBITDA Financial Results EBITDA Revenue Growth BRAIN Biotech AG Milestone Payment
Published on 12/05/2025 at 17:15, 42 minutes ago TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 17:00, 57 minutes ago Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once
Published on 12/05/2025 at 16:00, 1 hour 57 minutes ago SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 15:45, 2 hours 12 minutes ago Critical Elements announce la clôture d'un placement privé de 7,0 $ million ca par voie de prise ferme
Published on 12/05/2025 at 15:45, 2 hours 12 minutes ago Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement
Published on 12/05/2025 at 17:46, 10 minutes ago Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds
Published on 12/05/2025 at 17:00, 56 minutes ago EQS-Adhoc: The NAGA Group AG adjusts guidance for financial year 2025 following continued low volatility and weaker year-end performance
Published on 12/05/2025 at 16:25, 1 hour 31 minutes ago 4YFN26 Awards: Meet the Top 20 startups building the future
Published on 12/05/2025 at 16:10, 1 hour 46 minutes ago Reorganization of the Eckert & Ziegler Executive Board
Published on 12/05/2025 at 16:00, 1 hour 56 minutes ago EQS-Adhoc: TIN INN Holding AG implements financing strategy
Published on 12/05/2025 at 17:18, 38 minutes ago La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 38 minutes ago The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 2 hours 46 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 2 hours 46 minutes ago Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 3 hours 58 minutes ago RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE